Tag: YearEnd

Dianthus Chief Financial Officer Sells Off 20,000 Shares for Over $900,000 Following Strong Year-End Performance

In a recent derivative transaction on Dec. 4, 2025, CFO Ryan Savitz of Dianthus Therapeutics (NASDAQ:DNTH) sold 20,000…